Axiom Investors LLC DE Buys 190,417 Shares of Option Care Health, Inc. $OPCH

Key Points

• Axiom Investors LLC DE increased its stake in Option Care Health by 111.2%, acquiring an additional 190,417 shares during the first quarter.
• Option Care Health reported a 15.4% increase in revenue year-over-year, posting earnings of $0.41 per share for the last quarter, surpassing analysts' expectations.
• Analysts maintain a consensus rating of "Moderate Buy" for Option Care Health, with an average target price of $35.75 following several price objective upgrades.

Axiom Investors LLC DE lifted its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 111.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 361,615 shares of the company's stock after purchasing an additional 190,417 shares during the quarter. Axiom Investors LLC DE owned about 0.22% of Option Care Health worth $12,638,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. raised its holdings in Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares during the last quarter. Brooklyn Investment Group raised its holdings in Option Care Health by 186.6% in the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after acquiring an additional 780 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares during the last quarter. Bessemer Group Inc. raised its holdings in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after acquiring an additional 599 shares during the last quarter. Finally, Wealthquest Corp purchased a new position in Option Care Health in the 1st quarter worth approximately $66,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Price Performance

Shares of OPCH opened at $29.09 on Monday. The firm has a market cap of $4.72 billion, a PE ratio of 23.27, a P/E/G ratio of 1.77 and a beta of 0.83. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The firm has a fifty day simple moving average of $29.29 and a two-hundred day simple moving average of $31.54. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.30 EPS. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Upgrades and Downgrades

OPCH has been the subject of a number of recent analyst reports. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. JMP Securities boosted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. Eight research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Option Care Health currently has a consensus rating of "Moderate Buy" and an average target price of $35.75.

Insider Buying and Selling at Option Care Health

In related news, Director Timothy P. Sullivan acquired 20,000 shares of Option Care Health stock in a transaction dated Thursday, August 21st. The stock was purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the purchase, the director directly owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of Option Care Health stock in a transaction dated Wednesday, August 20th. The stock was bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the purchase, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.